Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics - Organic & Biomolecular Chemistry (RSC Publishing)
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Cytarabine
Metabolic pathway of ara-C | Download Scientific Diagram
Structures of gemcitabine and ara-C (cytarabine). | Download Scientific Diagram
Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule... Stock Photo, Picture And Royalty Free Image. Image 93261187.
AraC - drug review: dosage, side effects, action, buy AraC
Rooster© | ARA-C 40
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Ara-C metabolism. Ara-C: Cytarabine; Ara-CDP: Ara-C diphosphate;... | Download Scientific Diagram
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Cytarabine | C9H13N3O5 - PubChem
Clofarabine plus Cytarabine Compared to Cytarabine Alone in
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
1182-Low dose cytarabine | eviQ
Cytarabine
Sea to Ara C: Appendix
Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule... Royalty Free Cliparts, Vectors, And Stock Illustration. Image 26738002.
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML
Cytarabine - Wikipedia
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Cytarabine - (β-D-Arabinofuranosyl)cytosine, Cytarabine
